Elizabeth Bayliss to Multiple Chronic Conditions
This is a "connection" page, showing publications Elizabeth Bayliss has written about Multiple Chronic Conditions.
Connection Strength
2.323
-
Perceptions of Patient Portal Use for Advance Directive Documentation among Older Adults with Multiple Chronic Conditions. J Soc Work End Life Palliat Care. 2020 Jul-Sep; 16(3):238-249.
Score: 0.722
-
Managing Multiple Chronic Conditions during COVID-19 Among Patients with Social Health Risks. J Am Board Fam Med. 2024 Mar-Apr; 37(2):172-179.
Score: 0.234
-
Use of Latent Class Analysis and k-Means Clustering to Identify Complex Patient Profiles. JAMA Netw Open. 2020 12 01; 3(12):e2029068.
Score: 0.187
-
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. Trials. 2020 Jun 18; 21(1):542.
Score: 0.181
-
Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling. Health Qual Life Outcomes. 2019 Dec 19; 17(1):186.
Score: 0.175
-
Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment. BMJ Open. 2019 08 30; 9(8):e028438.
Score: 0.171
-
Adapting summary scores for the PROMIS-29 v2.0 for use among older adults with multiple chronic conditions. Qual Life Res. 2019 Jan; 28(1):199-210.
Score: 0.160
-
Evaluating the PROMIS-29 v2.0 for use among older adults with multiple chronic conditions. Qual Life Res. 2018 Nov; 27(11):2935-2944.
Score: 0.159
-
Research Priorities to Advance the Health and Health Care of Older Adults with Multiple Chronic Conditions. J Am Geriatr Soc. 2017 Jul; 65(7):1549-1553.
Score: 0.146
-
Engaging Stakeholders to Inform Clinical Practice Guidelines That Address Multiple Chronic Conditions. J Gen Intern Med. 2017 Aug; 32(8):883-890.
Score: 0.145
-
A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions. J Clin Epidemiol. 2019 09; 113:92-100.
Score: 0.042